Analyzing the impact of the European unitary patent system on worldwide biotechnology.
Following the deepest recession in generations, the European Union (EU) has proposed a plan to rebuild its economy that includes restructuring of its science and innovation system. In this context, the EU has rolled out a unitary patent system to improve technological development across European countries. This decision brings to light a new scientific and administrative scenario that will change the rules of innovation in Europe, with consequences for global biotechnology.